Unexpected severe hepatotoxicity of ciprofloxacine: two case reports

dc.authoridKURT, HASAN ANIL/0000-0001-7292-2248
dc.authoridAlan, Cabir/0000-0002-6024-4475
dc.contributor.authorAlan, Cabir
dc.contributor.authorKocoglu, Hasan
dc.contributor.authorErsay, Ahmet Resit
dc.contributor.authorErtung, Yunus
dc.contributor.authorKurt, Hasan Anil
dc.date.accessioned2025-01-27T21:04:03Z
dc.date.available2025-01-27T21:04:03Z
dc.date.issued2011
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractCiprofloxacin is a fluoroquinolone antibiotic that has a relatively low rate of occurence of adverse side effects. However, increasing evidences suggest that ciprofloxacin may cause unexpected severe liver damage. Especially, the risk of hepatotoxicity is significantly higher in elderly men receiving drug for a long time. In this article, 2 cases of unexpected severe hepatoxicity of ciprofloxacin are presented.
dc.identifier.doi10.3109/01480545.2010.495392
dc.identifier.endpage191
dc.identifier.issn0148-0545
dc.identifier.issn1525-6014
dc.identifier.issue2
dc.identifier.pmid21314468
dc.identifier.scopus2-s2.0-79951588560
dc.identifier.scopusqualityQ1
dc.identifier.startpage189
dc.identifier.urihttps://doi.org/10.3109/01480545.2010.495392
dc.identifier.urihttps://hdl.handle.net/20.500.12428/27536
dc.identifier.volume34
dc.identifier.wosWOS:000287581700012
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofDrug and Chemical Toxicology
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectComplication
dc.subjectciprofloxacin
dc.subjecthepatotoxicity
dc.titleUnexpected severe hepatotoxicity of ciprofloxacine: two case reports
dc.typeArticle

Dosyalar